Incannex Healthcare Limited (IXHL) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
分析师预估 每股收益(EPS)为 $-40.77 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.14 vs 预期 $-40.77 (超预期 +97.2%). 2025: 实际 $-40.80 vs 预期 $-28.80 (不及预期 -41.7%). 分析师准确度: 0%.
EPS 预测 — IXHL
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.14
vs Est –$40.77
▲ 3,476.4% off
2025
Actual –$40.80
vs Est –$28.80
▼ 29.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — IXHL
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 439.3% off
2025
Actual $0.000B
vs Est $0.000B
▼ 132.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
